BACKGROUND: Conformal or intensity-modulated radiation therapy can be improved by using a customized tongue-displacing (CTD) stent. These stents are designed to either move healthy oral tissues out of the path of the radiation beam or stabilize mobile tissues to allow more precise field control. METHODS: The authors describe CTD stent construction for both tongue-deviating and tongue-depressing applications. RESULTS: CTD stents enable clinicians to achieve more predictable and consistent radiation dosimetry planning while sparing greater volumes of healthy tissue from damage. They have been well tolerated by patients. CONCLUSIONS: Use of CTD stents results in increased oral mucosal sparing, ensures reproducible immobilization and is incorporated readily into the clinical practice of radiation oncology. Practical Implications. Clinicians can reduce or avoid significant morbidity to healthy oral tissues by using CTD stents. This can lead to better outcomes and improved quality of life for patients receiving head and neck radiation therapy.
BACKGROUND: Conformal or intensity-modulated radiation therapy can be improved by using a customized tongue-displacing (CTD) stent. These stents are designed to either move healthy oral tissues out of the path of the radiation beam or stabilize mobile tissues to allow more precise field control. METHODS: The authors describe CTD stent construction for both tongue-deviating and tongue-depressing applications. RESULTS: CTD stents enable clinicians to achieve more predictable and consistent radiation dosimetry planning while sparing greater volumes of healthy tissue from damage. They have been well tolerated by patients. CONCLUSIONS: Use of CTD stents results in increased oral mucosal sparing, ensures reproducible immobilization and is incorporated readily into the clinical practice of radiation oncology. Practical Implications. Clinicians can reduce or avoid significant morbidity to healthy oral tissues by using CTD stents. This can lead to better outcomes and improved quality of life for patients receiving head and neck radiation therapy.
Authors: Susannah Cleland; Scott B Crowe; Philip Chan; Benjamin Chua; Jodi Dawes; Lizbeth Kenny; Charles Y Lin; William R McDowall; Elise Obereigner; Tania Poroa; Kate Stewart; Tanya Kairn Journal: Tech Innov Patient Support Radiat Oncol Date: 2022-06-21
Authors: Mohamed Zaid; Eugene J Koay; Nimit Bajaj; Ryan Mathew; Lianchun Xiao; Anshuman Agrawal; Pearl Fernandes; Hannah Burrows; Millicent A Roach; Christopher T Wilke; Caroline Chung; Clifton D Fuller; Jack Phan; G Brandon Gunn; William H Morrison; Adam S Garden; Steven J Frank; David I Rosenthal; Michael Andersen; Adegbenga Otun; Mark S Chambers Journal: Oral Oncol Date: 2020-04-13 Impact factor: 5.337
Authors: Rafal Panek; Liam Welsh; Lauren C J Baker; Maria A Schmidt; Kee H Wong; Angela M Riddell; Dow-Mu Koh; Alex Dunlop; Dualta Mcquaid; James A d'Arcy; Shreerang A Bhide; Kevin J Harrington; Christopher M Nutting; Georgina Hopkinson; Cheryl Richardson; Carol Box; Suzanne A Eccles; Martin O Leach; Simon P Robinson; Kate L Newbold Journal: Clin Cancer Res Date: 2017-03-17 Impact factor: 12.531
Authors: Abdallah S R Mohamed; David I Rosenthal; Musaddiq J Awan; Adam S Garden; Esengul Kocak-Uzel; Abdelaziz M Belal; Ahmed G El-Gowily; Jack Phan; Beth M Beadle; G Brandon Gunn; Clifton D Fuller Journal: Radiat Oncol Date: 2016-07-26 Impact factor: 3.481
Authors: Christopher T Wilke; Mohamed Zaid; Caroline Chung; Clifton D Fuller; Abdallah S R Mohamed; Heath Skinner; Jack Phan; G Brandon Gunn; William H Morrison; Adam S Garden; Steven J Frank; David I Rosenthal; Mark S Chambers; Eugene J Koay Journal: 3D Print Med Date: 2017-11-16